| clinical trial solution: Virtual Clinical Trials National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, 2019-11-16 Successful drug development relies on accurate and efficient clinical trials to deliver the best and most effective pharmaceuticals and clinical care to patients. However, the current model for clinical trials is outdated, inefficient and costly. Clinical trials are limited by small sample sizes that do not reflect variations among patients in the real world, financial burdens on participants, and slow processes, and these factors contribute to the disconnect between clinical research and clinical practice. On November 28-29, the National Academies of Sciences, Engineering, and Medicine convened a workshop to investigate the current clinical trials system and explore the potential benefits and challenges of implementing virtual clinical trials as an enhanced alternative for the future. This publication summarizes the presentations and discussions from the workshop. |
| clinical trial solution: Sharing Clinical Trial Data Institute of Medicine, Board on Health Sciences Policy, Committee on Strategies for Responsible Sharing of Clinical Trial Data, 2015-04-20 Data sharing can accelerate new discoveries by avoiding duplicative trials, stimulating new ideas for research, and enabling the maximal scientific knowledge and benefits to be gained from the efforts of clinical trial participants and investigators. At the same time, sharing clinical trial data presents risks, burdens, and challenges. These include the need to protect the privacy and honor the consent of clinical trial participants; safeguard the legitimate economic interests of sponsors; and guard against invalid secondary analyses, which could undermine trust in clinical trials or otherwise harm public health. Sharing Clinical Trial Data presents activities and strategies for the responsible sharing of clinical trial data. With the goal of increasing scientific knowledge to lead to better therapies for patients, this book identifies guiding principles and makes recommendations to maximize the benefits and minimize risks. This report offers guidance on the types of clinical trial data available at different points in the process, the points in the process at which each type of data should be shared, methods for sharing data, what groups should have access to data, and future knowledge and infrastructure needs. Responsible sharing of clinical trial data will allow other investigators to replicate published findings and carry out additional analyses, strengthen the evidence base for regulatory and clinical decisions, and increase the scientific knowledge gained from investments by the funders of clinical trials. The recommendations of Sharing Clinical Trial Data will be useful both now and well into the future as improved sharing of data leads to a stronger evidence base for treatment. This book will be of interest to stakeholders across the spectrum of research-from funders, to researchers, to journals, to physicians, and ultimately, to patients. |
| clinical trial solution: Small Clinical Trials Institute of Medicine, Board on Health Sciences Policy, Committee on Strategies for Small-Number-Participant Clinical Research Trials, 2001-01-01 Clinical trials are used to elucidate the most appropriate preventive, diagnostic, or treatment options for individuals with a given medical condition. Perhaps the most essential feature of a clinical trial is that it aims to use results based on a limited sample of research participants to see if the intervention is safe and effective or if it is comparable to a comparison treatment. Sample size is a crucial component of any clinical trial. A trial with a small number of research participants is more prone to variability and carries a considerable risk of failing to demonstrate the effectiveness of a given intervention when one really is present. This may occur in phase I (safety and pharmacologic profiles), II (pilot efficacy evaluation), and III (extensive assessment of safety and efficacy) trials. Although phase I and II studies may have smaller sample sizes, they usually have adequate statistical power, which is the committee's definition of a large trial. Sometimes a trial with eight participants may have adequate statistical power, statistical power being the probability of rejecting the null hypothesis when the hypothesis is false. Small Clinical Trials assesses the current methodologies and the appropriate situations for the conduct of clinical trials with small sample sizes. This report assesses the published literature on various strategies such as (1) meta-analysis to combine disparate information from several studies including Bayesian techniques as in the confidence profile method and (2) other alternatives such as assessing therapeutic results in a single treated population (e.g., astronauts) by sequentially measuring whether the intervention is falling above or below a preestablished probability outcome range and meeting predesigned specifications as opposed to incremental improvement. |
| clinical trial solution: Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials Mark Chang, John Balser, Jim Roach, Robin Bliss, 2019-03-20 This is truly an outstanding book. [It] brings together all of the latest research in clinical trials methodology and how it can be applied to drug development.... Chang et al provide applications to industry-supported trials. This will allow statisticians in the industry community to take these methods seriously. Jay Herson, Johns Hopkins University The pharmaceutical industry's approach to drug discovery and development has rapidly transformed in the last decade from the more traditional Research and Development (R & D) approach to a more innovative approach in which strategies are employed to compress and optimize the clinical development plan and associated timelines. However, these strategies are generally being considered on an individual trial basis and not as part of a fully integrated overall development program. Such optimization at the trial level is somewhat near-sighted and does not ensure cost, time, or development efficiency of the overall program. This book seeks to address this imbalance by establishing a statistical framework for overall/global clinical development optimization and providing tactics and techniques to support such optimization, including clinical trial simulations. Provides a statistical framework for achieve global optimization in each phase of the drug development process. Describes specific techniques to support optimization including adaptive designs, precision medicine, survival-endpoints, dose finding and multiple testing. Gives practical approaches to handling missing data in clinical trials using SAS. Looks at key controversial issues from both a clinical and statistical perspective. Presents a generous number of case studies from multiple therapeutic areas that help motivate and illustrate the statistical methods introduced in the book. Puts great emphasis on software implementation of the statistical methods with multiple examples of software code (both SAS and R). It is important for statisticians to possess a deep knowledge of the drug development process beyond statistical considerations. For these reasons, this book incorporates both statistical and clinical/medical perspectives. |
| clinical trial solution: Clinical Research Michael J. McPhaul, Robert D. Toto, 2011 Clinical and translational research is a crucial link to the improvement of clinical care and practice. Many of the elements that are involved--physicians, nurses, pharmacists, laboratory testing, medical records--are also involved in the delivery of care to patients. Yet in the conduct of clinical research, these elements are arrayed in different configurations and constrained by rules and regulations that are distinct from those that guide the practice of medicine. In parallel with these considerations, the conduct of clinical research demands a specific skill set. Specialized tools are required to formulate and design informative clinical trials and to interpret the findings from such experiments--Provided by publisher. |
| clinical trial solution: Clinical Trials Handbook Shayne Cox Gad, 2009-06-17 Best practices for conducting effective and safe clinical trials Clinical trials are arguably the most important steps in proving drug effectiveness and safety for public use. They require intensive planning and organization and involve a wide range of disciplines: data management, biostatistics, pharmacology, toxicology, modeling and simulation, regulatory monitoring, ethics, and particular issues for given disease areas. Clinical Trials Handbook provides a comprehensive and thorough reference on the basics and practices of clinical trials. With contributions from a range of international authors, the book takes the reader through each trial phase, technique, and issue. Chapters cover every key aspect of preparing and conducting clinical trials, including: Interdisciplinary topics that have to be coordinated for a successful clinical trialData management (and adverse event reporting systems) Biostatistics, pharmacology, and toxicology Modeling and simulation Regulatory monitoring and ethics Particular issues for given disease areas-cardiology, oncology, cognitive, dementia, dermatology, neuroscience, and more With unique information on such current issues as adverse event reporting (AER) systems, adaptive trial designs, and crossover trial designs, Clinical Trials Handbook will be a ready reference for pharmaceutical scientists, statisticians, researchers, and the many other professionals involved in drug development. |
| clinical trial solution: Handbook of SOPs for Good Clinical Practice, Second Edition Celine Clive, 2004-02-17 Completely revised and updated, the second edition of a classic reference, Handbook of SOPs for Good Clinical Practice provides templates of SOPs ready for adaptation to your requirements and immediate use. This allows you to create new SOPs or benchmark your existing SOPs against an internationally accepted set of SOPs. The book includes a CD-ROM containing an electronic copy of each of the SOPs and forms in the handbook so that you can easily customize the text to reflect your organization's processes. The author uses language ranging from the specific to the very general, depending on the activity described and the number of the existing regulations governing the activity. This provides you with a starting point for the development of your organization's SOPs, saving you the time and money that would normally be spent researching and documenting each of the procedures described. Modifying the SOPs supplied by this book will be a much more efficient task than developing new ones from scratch. Containing templates for SOPs and forms applicable to sponsors, study sites, and Institutional Review Boards (IRBs), Handbook of SOPs for Good Clinical Practice, Second Edition gives you the tools needed to develop effective SOPs for your organization. |
| clinical trial solution: Clinical Pharmacy Education, Practice and Research Dixon Thomas, 2018-11-23 Clinical Pharmacy Education, Practice and Research offers readers a solid foundation in clinical pharmacy and related sciences through contributions by 83 leading experts in the field from 25 countries. This book stresses educational approaches that empower pharmacists with patient care and research competencies. The learning objectives and writing style of the book focus on clarifying the concepts comprehensively for a pharmacist, from regular patient counseling to pharmacogenomics practice. It covers all interesting topics a pharmacist should know. This book serves as a basis to standardize and coordinate learning to practice, explaining basics and using self-learning strategies through online resources or other advanced texts. With an educational approach, it guides pharmacy students and pharmacists to learn quickly and apply. Clinical Pharmacy Education, Practice and Research provides an essential foundation for pharmacy students and pharmacists globally. - Covers the core information needed for pharmacy practice courses - Includes multiple case studies and practical situations with 70% focused on practical clinical pharmacology knowledge - Designed for educational settings, but also useful as a refresher for advanced students and researchers |
| clinical trial solution: Clinical Trial Modernization Harry Yang, Liang Zhao, 2025-05-26 As the pharmaceutical industry navigates this new era of technological innovation, the integration of AI, big data, and advanced analytics into clinical trials holds immense potential to transform drug development. Clinical Trial Modernization: Technological, Operational, and Regulatory Advances provides a comprehensive overview of the current trends, challenges, and opportunities in modernizing clinical trials, offering a roadmap for stakeholders in this evolving field. This book serves as a valuable resource for professionals, researchers, and regulators, providing actionable insights into the future of clinical trials and their critical role in bringing new therapies to market faster and more effectively. |
| clinical trial solution: Clinical Trial Optimization Using R Alex Dmitrienko, Erik Pulkstenis, 2019-03-22 Clinical Trial Optimization Using R explores a unified and broadly applicable framework for optimizing decision making and strategy selection in clinical development, through a series of examples and case studies. It provides the clinical researcher with a powerful evaluation paradigm, as well as supportive R tools, to evaluate and select among simultaneous competing designs or analysis options. It is applicable broadly to statisticians and other quantitative clinical trialists, who have an interest in optimizing clinical trials, clinical trial programs, or associated analytics and decision making. This book presents in depth the Clinical Scenario Evaluation (CSE) framework, and discusses optimization strategies, including the quantitative assessment of tradeoffs. A variety of common development challenges are evaluated as case studies, and used to show how this framework both simplifies and optimizes strategy selection. Specific settings include optimizing adaptive designs, multiplicity and subgroup analysis strategies, and overall development decision-making criteria around Go/No-Go. After this book, the reader will be equipped to extend the CSE framework to their particular development challenges as well. |
| clinical trial solution: Understanding IBM Workplace Strategy and Products Ron Sebastian, Douglas W. Spencer, 2005-10 Annotation IBM Workplace represents an entire portfolio of IBM products, new and existing, that focuses on increasing people's productivity in a new way. In this book, IBM Software Live! Program Director Douglas Spencer and Senior Lotus Consultant Ron Sebastian start with an introduction to people productivity in the context of IBM's On Demand Business vision. Then the IBM Workplace strategy and products are described. You will see how the underlying componentized software infrastructure of IBM Workplace provides the flexibility businesses need in the emerging on demand world. You will see how many users without traditional desks such as an outbound sales force, factory floor staff, airline pilots, etc. can collaborate with others boosting the productivity of the entire organization, trading partners, and customers. The authors then provide an overview of the key product lines that implement the IBM Workplace vision including IBM Workplace, WebSphere Portal, Lotus Notes and Domino, and WebSphere Everyplace. You will learn how the new IBM Workplace client technology for these products combines the rich user experience of client/server with the cost characteristics of Web-based applications, giving users the best of both worlds. In the final chapter, the authors explore industry-specific people productivity solutions tailored for the needs of specific industries including aerospace, defense, automotive, banking, financial markets, consumer products, electronics, utilities, government, health care, insurance, life sciences, retail, and telecommunications, etc. The Foreword, by IBM Software Group General Manager of Workplace, Portal, and Collaboration Software, Michael D. Rhodin, provides an insider's perspective on the thinking behind IBM Workplace. To help you stay current, this book comes with your personal password for accessing the companion Web site which offers up-to-the-minute IBM Workplace news, More on the Web links, and additional resources. |
| clinical trial solution: Transcending Horizons Through Innovative Global Practices Editor:Alok Bansal, Yogeshwari Phatak, I C Gupta, Rajendra Jain, 2009 Papers presented at a conference. |
| clinical trial solution: Pain Procedures in Clinical Practice E-Book Ted A. Lennard, David G Vivian, Stevan DOW Walkowski, Aneesh K. Singla, 2011-06-11 In the 3rd Edition of Pain Procedures in Clinical Practice, Dr. Ted Lennard helps you offer the most effective care to your patients by taking you through the various approaches to pain relief used in physiatry today. In this completely updated, procedure-focused volume, you’ll find nearly a decade worth of new developments and techniques supplemented by a comprehensive online video collection of how-to procedures at www.expertconsult.com. You’ll also find extensive coverage of injection options for every joint, plus discussions of non-injection-based pain relief options such as neuromuscular ultrasound, alternative medicines, and cryotherapy. Offer your patients today’s most advanced pain relief with nearly a decade worth of new developments and techniques, masterfully presented by respected physiatrist Ted Lennard, MD. Make informed treatment decisions and provide effective relief with comprehensive discussions of all of the injection options for every joint. Apply the latest non-injection-based treatments for pain relief including neuromuscular ultrasound, alternative medicines, and cryotherapy. See how to get the best results with a comprehensive video collection of how-to procedures at www.expertconsult.com, and access the complete text and images online. |
| clinical trial solution: Biomaterials for Musculoskeletal Regeneration Bikramjit Basu, 2016-11-01 This book covers the basics of the biomaterials science its applications to bone tissue engineering. The introductory section describes the most necessary concepts and techniques related to the cell and molecular biology with a particular focus on evaluating the biocompatibility property. The layout of this book facilitates easier understanding of the area of bone tissue engineering. The book integrates the Materials Science and Biological Science. It covers processing and basic material properties of various biocompatible metals and ceramics-based materials, in vitro and in vivo biocompatibility and toxicity assessment in the context of bone tissue engineering, and processing and properties of metal-, ceramic- and polymer-based biocomposites, including the fabrication of porous scaffold materials. The book can be used as a textbook for senior undergraduate and graduate coursework. It will also be a useful reference for researchers and professionals working in the area. |
| clinical trial solution: Blockchain-Enabled Solutions for the Pharmaceutical Industry Ritika Wason, Parul Arora, Parma Nand, Vishal Jain, Vinay Kukreja, 2025-01-29 The 25 chapters in this volume serve as a comprehensive guide to understanding and implementing blockchain-enabled solutions in the pharmaceutical industry. The pharmaceutical industry is undergoing a holistic transformation, where innovation is key to addressing complex challenges and enabling user-centric, customized services. This book explores the potential applications of blockchain technology in revolutionizing pharmaceutical processes. By integrating blockchain fundamentals, the pharmaceutical industry can enhance transparency, security, and efficiency in areas such as supply chain management, patient safety, and more. Blockchain can also improve regulatory compliance, streamline clinical trials, and protect data integrity. Furthermore, it enables secure transactions, reduces the prevalence of counterfeit drugs, and strengthens patient privacy and data management. Some of the subjects readers will find the volume covers include: How blockchain technology can revolutionize the healthcare sector by enabling a secure, decentralized, and tamper-proof system for handling patient data, and facilitating seamless information sharing across various healthcare providers • how blockchain transforms the pharmaceutical industry by enhancing drug traceability, ensuring product authenticity, and reducing counterfeit drugs • a comprehensive blockchain-based framework to improve the pharmaceutical supply chain from manufacturers to end consumers • how the Pharma-RBT solution utilizes blockchain technology to protect personally identifiable information (PII) during drug trials • the use of blockchain-based smart contracts to automate and streamline payment processes reducing transaction times and minimizing human errors • surveys how blockchain can ensure the validity of pharmaceutical products by providing an immutable and transparent ledger that tracks each phase of a drug’s lifecycle, from production to the end consumer • how blockchain can enhance the security of smart medicine vending machines • how blockchain can improve the kidney transplantation process by enhancing the security, traceability, and efficiency of donor-recipient matching, organ transportation, and post-operative care • how blockchain can contribute to the development of the metaverse by enabling decentralized ownership of virtual assets • how blockchain can improve clinical trials by enhancing transparency, efficiency, and ethical conduct in drug development • how blockchain technology can revolutionize the drug recall process • how integrating hybrid technologies with blockchain can enhance smart healthcare systems • how the metaverse can transform healthcare by offering immersive virtual environments for medical training, patient education, and remote consultations. Audience The book will appeal to researchers, scientists, and professionals in the biomedical and pharmaceutical industries, as well as computer scientists and experts in blockchain technology, cybersecurity, and logistics. |
| clinical trial solution: Oncology Nursing in the Ambulatory Setting Patricia Corcoran Buchsel, Connie Henke Yarbro, 2005 This book provides the very lastest in position statements, and new, forward-thinking in administrative strategies. Addresses fiscal management of outpatient cancer centers, including financial systems models, use of CPT codes, cost effectivness and clinical applications of evidence-based practice guidelines. |
| clinical trial solution: 11th Mediterranean Conference on Medical and Biological Engineering and Computing 2007 Tomaz Jarm, Peter Kramar, Anze Zupanic, 2007-11-12 Biomedical engineering brings together bright minds from diverse disciplines, ranging from engineering, physics, and computer science to biology and medicine. This book contains the proceedings of the 11th Mediterranean Conference on Medical and Biological Engineering and Computing, MEDICON 2007, held in Ljubljana, Slovenia, June 2007. It features relevant, up-to-date research in the area. |
| clinical trial solution: Brenner and Rector's The Kidney E-Book Alan S. L. Yu, Glenn M. Chertow, Valerie Luyckx, Philip A. Marsden, Karl Skorecki, Maarten W. Taal, 2015-10-25 Overcome the toughest clinical challenges in nephrology with Brenner & Rector’s The Kidney -- the most well-known nephrology resource in the world. A diverse team of more than 200 international contributors brings you the latest knowledge and best practices on every front in nephrology worldwide. From basic science and pathophysiology to clinical best practices, Brenner & Rector’s The Kidney is your go-to resource for any stage of your career. Review of the basic science that underpins clinical nephrology, comprehensive selection of the most important bibliographical sources in nephrology, and Board Review-style questions help you prepare for certification or recertification. Coverage of kidney health and disease from pre-conception through fetal and infant health, childhood, adulthood, and into old age. Expanded sections and chapter on global perspective and ethical considerations. Uniform terminology and nomenclature in line with emerging consensus in world kidney community. More than 700 full-color high-quality photographs as well as carefully chosen figures, algorithms, and tables to illustrate essential concepts, nuances of clinical presentation and technique, and decision making provide a visual grasp and better understanding of critical information. Internationally diverse, trusted guidance and perspectives from a team of well-respected global contributors . An editorial team headed by Dr. Skorecki and handpicked by Dr. Brenner ensures the ongoing adherence to previous standards of excellence. All chapters have been extensively updated or entirely rewritten by authorities in their respective fields. The latest clinical information including recent clinical trials, genetic causes of kidney disease, cardiovascular and renal risk prediction in chronic kidney disease, new paradigms in fluid and electrolyte management, and pediatric kidney disease, keep you current with the rapid development of care and research worldwide. |
| clinical trial solution: Blockchain and Public Law Pollicino, Oreste, De Gregorio, Giovanni, 2021-07-31 This important and topical book provides a comprehensive overview of the challenges raised by blockchain from the perspective of public law. It considers the ways in which traditional categories of public law such as sovereignty, citizenship and territory are shaped, as well as the impact of blockchain technology on fundamental rights and democratic values. |
| clinical trial solution: Managing Medical Technological Innovations: Exploring Multiple Perspectives Tugrul U Daim, Alexander Brem, 2019-12-23 This book addresses the issue of modern medical innovations management through an inductive approach by looking into cases before putting forward solutions in terms of strategies and tools. It provides a model for the designing and implementation of effective healthcare technology management (HTM) systems in hospitals and healthcare provider settings, as well as promotes a new method of analysis of hospital organization for decision-making regarding technology to show how systematic management using a strategy that balances bottom-up and top-down driven innovations, can deliver better medical technological advances.Managing Medical Technological Innovations is organized in three parts. Part 1 covers innovation strategies, laying the groundwork and concepts in design thinking. Part 2 follows by presenting the tools available for implementation. And finally, Part 3 uses the case studies of pharmaceutical firms in China and hospital medical record management in Holland to illustrate how these ideas and methodologies have been applied.This book is suitable for healthcare administrators, management, and IT personnel involved in the planning, expansion and maintaining of healthcare technology management and organisation seeking a reference with most recent approaches and cases from an international context; researchers seeking new approaches to apply to emerging medical technologies in different regions; and graduate students who are either doing their research or taking introductory as well as advanced courses in engineering and technology management in different parts of the world. |
| clinical trial solution: Revolutionising Medical Imaging with Computer Vision and Artificial Intelligence Seema Bhatnagar, Priyanka Narad, Rajashree Das, Debarati Paul, 2024-09-24 This collection aims to explore the transformative potential of computer vision and artificial intelligence (AI) in revolutionizing medical imaging. Medical imaging is still in a state of infancy. The interpretation of medical images is often time-consuming and subject to human error. By leveraging computer vision algorithms and AI technologies, medical imaging can be enhanced with automated analysis, pattern recognition, and predictive modelling, leading to improved accuracy, speed, and clinical outcomes. This collection provides an overview of the current state, challenges, and prospects of integrating computer vision and AI techniques into existing medical imaging technologies. Medical imaging has the potential to create a paradigm shift in healthcare in future enhancing diagnostic accuracy, personalised treatment, and overall patient care. While challenges related to data quality, interpretability, and ethics must be navigated, the future for AI based imaging technology is bright. |
| clinical trial solution: Designing and Operating a Data Reservoir Mandy Chessell, Nigel L Jones, Jay Limburn, David Radley, Kevin Shank, IBM Redbooks, 2015-05-26 Together, big data and analytics have tremendous potential to improve the way we use precious resources, to provide more personalized services, and to protect ourselves from unexpected and ill-intentioned activities. To fully use big data and analytics, an organization needs a system of insight. This is an ecosystem where individuals can locate and access data, and build visualizations and new analytical models that can be deployed into the IT systems to improve the operations of the organization. The data that is most valuable for analytics is also valuable in its own right and typically contains personal and private information about key people in the organization such as customers, employees, and suppliers. Although universal access to data is desirable, safeguards are necessary to protect people's privacy, prevent data leakage, and detect suspicious activity. The data reservoir is a reference architecture that balances the desire for easy access to data with information governance and security. The data reservoir reference architecture describes the technical capabilities necessary for a system of insight, while being independent of specific technologies. Being technology independent is important, because most organizations already have investments in data platforms that they want to incorporate in their solution. In addition, technology is continually improving, and the choice of technology is often dictated by the volume, variety, and velocity of the data being managed. A system of insight needs more than technology to succeed. The data reservoir reference architecture includes description of governance and management processes and definitions to ensure the human and business systems around the technology support a collaborative, self-service, and safe environment for data use. The data reservoir reference architecture was first introduced in Governing and Managing Big Data for Analytics and Decision Makers, REDP-5120, which is available at: http://www.redbooks.ibm.com/redpieces/abstracts/redp5120.html. This IBM® Redbooks publication, Designing and Operating a Data Reservoir, builds on that material to provide more detail on the capabilities and internal workings of a data reservoir. |
| clinical trial solution: Clinical Trials in Oncology, Third Edition Stephanie Green, Jacqueline Benedetti, Angela Smith, John Crowley, 2012-05-09 The third edition of the bestselling Clinical Trials in Oncology provides a concise, nontechnical, and thoroughly up-to-date review of methods and issues related to cancer clinical trials. The authors emphasize the importance of proper study design, analysis, and data management and identify the pitfalls inherent in these processes. In addition, the book has been restructured to have separate chapters and expanded discussions on general clinical trials issues, and issues specific to Phases I, II, and III. New sections cover innovations in Phase I designs, randomized Phase II designs, and overcoming the challenges of array data. Although this book focuses on cancer trials, the same issues and concepts are important in any clinical setting. As always, the authors use clear, lucid prose and a multitude of real-world examples to convey the principles of successful trials without the need for a strong statistics or mathematics background. Armed with Clinical Trials in Oncology, Third Edition, clinicians and statisticians can avoid the many hazards that can jeopardize the success of a trial. |
| clinical trial solution: Innovation in Clinical Trial Methodologies Peter Schueler, 2020-11-01 Innovation in Clinical Trial Methodologies: Lessons Learned during the Corona Pandemic presents a selection of updated chapters from Re-Engineering Clinical Trials that feature innovative options and methods in clinical trials. The Coronavirus pandemic is an accelerator for digitalization in many industries, including clinical trials. This book considers best practices, alternative study concepts requiring fewer patients, studies with less patient interaction, the design of virtualized protocols, and moving from data to decisions. This book will be helpful to pharmacologists, physicians and clinical researchers involved in the process of clinical development and clinical trial design. - Considers multiple digital and virtual strategies - Explores best practices, including the use of reduced patient involvement - Brings together expert, trusted information to increase the efficiency and effectiveness of clinical trials |
| clinical trial solution: Diarrhoeal Diseases Research , 1986-03 |
| clinical trial solution: I-Byte Healthcare March 2021 IT Shades, 2021-03-23 This document brings together a set of latest data points and publicly available information relevant for Healthcare Industry. We are very excited to share this content and believe that readers will benefit from this periodic publication immensely. |
| clinical trial solution: Learning to Compete in European Universities Maureen McKelvey, Magnus Holmén, 2010-01-01 This title addresses the critical issue of how and why European universities are changing and learning to compete. |
| clinical trial solution: Cancer Nursing Connie Henke Yarbro, Debra Wujcik, Barbara Holmes Gobel, 2016-09-19 Cancer Nursing: Principles and Practice, Eighth Edition continues as the gold standard in oncology nursing. With contributions from the foremost experts in the field, it has remained the definitive reference on the rapidly changing science and practice of oncology nursing for more than 25 years. Completely updated and revised to reflect the latest research and developments in the care of patients with cancer, the Eighth Edition includes new chapters on the biology of cancer, sleep disorders, and palliative care across the cancer continuum. The Eighth Edition also includes significant updates to the basic science chapters to reflect recent increases in scientific knowledge, especially relating to genes and cancer. Also heavily revised are the sections devoted to the dynamics of cancer prevention, detection, and diagnosis, as well as treatment, oncologic emergencies, end of life care, and professional and legal issues for oncology nurses. |
| clinical trial solution: T Bytes Platforms & Applications ITShades.com, 2020-10-28 This document brings together a set of latest data points and publicly available information relevant for Platforms & Applications Industry. We are very excited to share this content and believe that readers will benefit from this periodic publication immensely. |
| clinical trial solution: Data governance in African health research: ELSI challenges and solutions Donrich Thaldar, Simisola Oluwatoyin Akintola, Bonginkosi Shozi, 2025-04-02 Data protection legislation is increasingly being enacted in African countries. Additionally, the African Union recently adopted the AU Data Protection Framework. How are these legal and policy developments influencing established ethics notions about data governance in health research? For example, is broad or tiered consent to research participation sufficient, or does new legislation require specific consent? How do individual rights in data interact with communitarian values? Should health research receive special treatment from a data protection regulatory perspective? How should African countries approach AI in healthcare? This research topic aims to identify and analyse ELSI challenges in contemporary data governance in African health research, and to develop possible solutions for such challenges. Articles in this research topic will aim to assist policy-makers, health researchers and ELSI practitioners in Africa to better navigate and—where relevant, improve—data governance in African health research. Perspective-style articles, as well as more in-depth research articles are welcome. While articles can analyse fundamental theoretical issues, application-oriented articles and articles that explore lessons learnt in practice are especially encouraged. Authors should address one or more of following (inter-related) themes within the research topic of data governance in African health research: 1) Conflicts between new legal and policy developments and established ethics notions. 2) Africanisation, decolonisation, and intra-African rule-harmonisation. 3) The evolution of informed consent and the role of trust. 4) The various legal, ethical and social dimensions or meanings of data, and how these dimensions interact. 5) Power and control. This includes individual, institutional, ethnic, community, and national claims to data. It also includes existing and proposed structures of control of data, such as data trusts, and data transfer agreements (DTAs). 6) Engagement with data protection regulatory authorities. 7) Artificial intelligence and Big Data. |
| clinical trial solution: IASLC Thoracic Oncology E-Book Harvey Pass, David Ball, Giorgio Scagliotti, 2017-04-21 Global experts, in conjunction with the International Association for the Study of Lung Cancer, bring you up to date with today's best approaches to lung cancer diagnosis, treatment, and follow-up. IASLC Thoracic Oncology, 2nd Edition, keeps you abreast of the entire scope of this fast-changing field, from epidemiology to diagnosis to treatment to advocacy. Written in a straightforward, practical style for the busy clinician, this comprehensive, multidisciplinary title is a must-have for anyone involved in the care of patients with lung cancer and other thoracic malignancies. - Offers practical, relevant coverage of basic science, epidemiology, pulmonology, medical and radiation oncology, surgery, pathology, palliative care, nursing, and advocacy. - Provides authoritative guidance from the IASLC – the only global organization dedicated to the study of lung cancer. - Includes new content on molecular testing, immunotherapy, early detection, staging and the IASLC staging system, surgical resection for stage I and stage II lung cancer, and stem cells in lung cancer. - Features a new full-color design throughout, as well as updated diagnostic algorithms. - Expert ConsultTM eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, Q&As, and references from the book on a variety of devices. |
| clinical trial solution: Research Anthology on Blockchain Technology in Business, Healthcare, Education, and Government Management Association, Information Resources, 2020-09-30 Even though blockchain technology was originally created as a ledger system for bitcoin to operate on, using it for areas other than cryptocurrency has become increasingly popular as of late. The transparency and security provided by blockchain technology is challenging innovation in a variety of businesses and is being applied in fields that include accounting and finance, supply chain management, and education. With the ability to perform such tasks as tracking fraud and securing the distribution of medical records, this technology is key to the advancement of many industries. The Research Anthology on Blockchain Technology in Business, Healthcare, Education, and Government is a vital reference source that examines the latest scholarly material on trends, techniques, and uses of blockchain technology applications in a variety of industries, and how this technology can further transparency and security. Highlighting a range of topics such as cryptography, smart contracts, and decentralized blockchain, this multi-volume book is ideally designed for academics, researchers, industry leaders, managers, healthcare professionals, IT consultants, engineers, programmers, practitioners, government officials, policymakers, and students. |
| clinical trial solution: Drug Discovery and Clinical Research SK Gupta, 2011-06 The Drug Discovery and Clinical Research bandwagon has been joined by scientists and researchers from all fields including basic sciences, medical sciences, biophysicists, biotechnologists, statisticians, regulatory officials and many more. The joint effort and contribution from all is translating into the fast development of this multi-faceted field. At the same time, it has become challenging for all stakeholders to keep abreast with the explosion in information. The race for the finish-line leaves very little time for the researchers to update themselves and keep tabs on the latest developments in the industry. To meet these challenges, this book entitled Drug Discovery and Clinical Research has been compiled. All chapters have been written by stalwarts of the field who have their finger on the pulse of the industry. The aim of the book is to provide succinctly within one cover, an update on all aspects of this wide area. Although each of the chapter dealt here starting from drug discovery and development, clinical development, bioethics, medical devices, pharmacovigilance, data management, safety monitoring, patient recruitment, etc. are topics for full-fledged book in themselves, an effort has been made via this book to provide a bird’s eye view to readers and help them to keep abreast with the latest development despite constraints of time. It is hoped that the book will contribute to the growth of readers, which should translate into drug discovery and clinical research industry’s growth. |
| clinical trial solution: Cholera Dhiman Barua, William B. Greenough III, 2013-11-11 Research on cholera has contributed both to knowledge of the epidemic in particular, and to a broader understanding of the fundamental ways in which cells communicate with each other. This volume presents current knowledge in historical perspective to enable the practitioner to treat cholera in a more effective manner, and to provide a comprehensive review for the researcher. |
| clinical trial solution: Commonwealth Heads of Government Meeting 2007 Commonwealth Secretariat, 2007 Presents current thought and pertinent analysis on Commonwealth issues and challenges. In-depth articles and case studies focus on topical issues, including the theme of the 2007 Commonwealth Heads of Government Meeting: 'Transforming Commonwealth Societies to achieve political, economic and human development.' |
| clinical trial solution: Diarrhoeal Diseases Research , 1990-03 |
| clinical trial solution: Infectious Diseases Sherwood L. Gorbach, John G. Bartlett, Neil R. Blacklow, 2004 The Third Edition of this definitive reference provides comprehensive guidelines on the diagnosis, treatment, and prevention of every infectious disease seen in current clinical practice. More than 300 world-class practitioners detail the full range of clinical infections, microorganisms, diagnostic tests, and antimicrobial therapies. Coverage includes chapters on surgical infections written by preeminent surgeons and up-to-the-minute information on HIV infection. A comprehensive antimicrobial drugs section includes tables that provide at-a-glance prescribing information. New Third Edition chapters cover bioterrorism, hospital infections, emerging infections, human herpesvirus-8, West Nile virus, food safety, linezolid and quinupristin/dalfopristin, molecular diagnostics, and diagnostic significance of nonspecific laboratory abnormalities. |
| clinical trial solution: Planning, Writing and Reviewing Medical Device Clinical and Performance Evaluation Reports (CERs/PERs) Joy Frestedt, 2024-09-19 A Practical Guide to Planning, Writing, and Reviewing Medical Device Clinical Evaluation Reports guides readers through clinical data evaluation of medical devices, in compliance with the EU MDR requirements and other similar regulatory requirements throughout the world. This book brings together knowledge learned as the author constructed hundreds of CERs and taught thousands of learners on how to conduct clinical data evaluations. This book will support training for clinical engineers, clinical evaluation scientists, and experts reviewing medical device CERs, and will help individual writers, teams and companies to develop stronger, more robust CERs. - Identifies and explains data analysis for clinical evaluation of medical devices - Teaches readers how to understand and evaluate medical device performance and safety in the context of new regulations - Provides analysis of new clinical evaluation criteria in the context of medical device design as well as in-hospital deployment and servicing |
| clinical trial solution: The Open Group OG0-093 Exam Practice Questions Brian Birds, The Open Group works with customers and suppliers of technology products and services, and with consortia and other standards organizations to capture, clarify, and integrate current and emerging requirements, establish standards and policies, and share best practices. Our standards ensure openness, interoperability, and consensus. |
| clinical trial solution: A Quick Guide to Clinical Trials Madhu Davies, Faiz Kermani, 2008 |
